Daiichi Suntory Pharma (Rights To 6R-BH4) Overview
Status
Acquired/Merged
Latest Deal Type
Asset Purch.
Financing Rounds
1
Daiichi Suntory Pharma (Rights To 6R-BH4) General Information
Description
A drug development and marketing right in Japan. The drug development right is associated to treat cardiovascular indications and genetic disease phenylketonuria (PKU).